RealFeedApp JOTROL dose taken orally over 12 weeks
Jupiter Neurosciences initiated Phase 2a trial RESET using the JOTROL micellar formulation. The clinical study involves 30 participants with Parkinson's disease.
- Field
- ageing and longevity
- What they did
- Jupiter Neurosciences has started Phase 2a clinical trials of JOTROL (a micellar form of resveratrol) with the first Parkinson's patients to test its effectiveness.
- Why it matters
- Researchers hope the improved formula will help the body absorb resveratrol better, which has previously been studied in the context of longevity.
#resveratrol#parkinsons#clinical trial#jupiter neurosciences#reset trial
